Home/Filings/4/0001486189-21-000014
4//SEC Filing

Fawcett Mark 4

Accession 0001486189-21-000014

CIK 0001479681other

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 1:26 PM ET

Size

9.1 KB

Accession

0001486189-21-000014

Insider Transaction Report

Form 4
Period: 2021-02-25
Fawcett Mark
Director
Transactions
  • Purchase

    Warrants to Puchase common stock

    2019-03-21$6.67/sh+3,598$23,9993,598 total
    Exercise: $6.67From: 2019-03-21Exp: 2024-12-31Common Stock (3,598 underlying)
  • Other

    Common Stock

    2021-01-28$2.04/sh+268,263$547,257277,259 total
  • Purchase

    Director Stock Option (right to buy)

    2020-08-05+85,12085,120 total
    Common Stock (85,120 underlying)
Footnotes (2)
  • [F1]Acquired as per Merger Transaction exchange
  • [F2]10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029 45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027 30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024

Issuer

Clinigence Holdings, Inc.

CIK 0001479681

Entity typeother

Related Parties

1
  • filerCIK 0001664134

Filing Metadata

Form type
4
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 1:26 PM ET
Size
9.1 KB